In patients with MASLD, precancerous lesions were positively associated with age and male gender, while negatively associated with advanced fibrosis.

In patients with IBD on maintenance IFX, use of 5-ASA and immunomodulators does not significantly reduce flares, infections, or adverse reactions.

Black patients face higher complications related to inflammatory bowel disease than White patients, according to a study presented at DDW 2025.

Patients with gastroesophageal reflux disease are at increased risk of developing lung cancer, according to a study presented at DDW 2025.

In biologic-naive patients with CD, there were no differences in clinical remission or disease progression between those who received risankizumab vs ustekinumab.

Fall history, sodium-glucose cotransporter 2 inhibitor use, and age were independent fall predictors. HealthDay News — Sodium-glucose cotransporter 2 (SGLT2) inhibitor use is an independent risk ...

US health officials directed food companies to voluntarily phase out petroleum-based synthetic dyes by the end of 2026. HealthDay News — The push to remove artificial colors from U.S. foods is gaining ...

Proportion of adult managed care organizations with access to cardioprotective medications varied from 24 to 100% for SGLT2 inhibitors and 0 to 99% for GLP-1 receptor agonists. HealthDay News — Many ...

The TRIUMpH studies met all primary and secondary endpoints. Topline data were announced from two phase 3 studies evaluating tegoprazan in patients with gastroesophageal reflux disease (GERD). The ...

A new study reveals that many perceived benefits of gluten-free products, such as weight control and diabetes management, are ...

Self-help cognitive behavioral therapy for irritable bowel syndrome was successfully delivered via mobile application.